Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).
For the
three
months ended in Sep. 2022, PLx Pharmaspent€0.00 Mil on purchasing property, plant, equipment.
It gained€0.00 Mil from selling property, plant, and equipment.
It spent€0.00 Mil on purchasing business.
It gained€0.00 Mil from selling business.
It spent€0.00 Mil on purchasing investments.
It gained€0.00 Mil from selling investments.
It paid€0.00Mil for net Intangibles purchase and sale.
And it paid€0.00 Mil for other investing activities.
In all, PLx Pharmagained€0.00 Mil on investment activities in financial market and operating subsidiaries for the
three
months ended in Sep. 2022.
PLx Pharma Cash Flow from Investing Historical Data
The historical data trend for PLx Pharma's Cash Flow from Investing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).
If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).
Likewise, if a company buys another company for cash, this will reduce their cash position.
PLx Pharma's Cash Flow from Investing for the fiscal year that ended in Dec. 2021 is calculated as:
Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PLx Pharma (FRA:1D5A) Cash Flow from Investing Explanation
PLx Pharma's purchase of property, plant, equipment for the
three
months ended in Sep. 2022 was €0.00 Mil. It means PLx Pharma spent €0.00 Mil on purchasing property, plant, equipment.
In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.
In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
PLx Pharma's sale of property, plant, equipment for the
three
months ended in Sep. 2022 was €0.00 Mil. It means PLx Pharma gained €0.00 Mil from selling property, plant, and equipment.
3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.
PLx Pharma's purchase of business for the
three
months ended in Sep. 2022 was €0.00 Mil. It means PLx Pharma spent €0.00 Mil on purchasing business.
4. Sale Of Business:
Sale of business indicates the amount gained from selling business.
PLx Pharma's sale of business for the
three
months ended in Sep. 2022 was €0.00 Mil. It means PLx Pharma gained €0.00 Mil from selling business.
5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.
PLx Pharma's purchase of investment for the
three
months ended in Sep. 2022 was €0.00 Mil. It means PLx Pharma spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.
6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.
PLx Pharma's sale of investment for the
three
months ended in Sep. 2022 was €0.00 Mil. It means PLx Pharma gained €0.00 Mil from selling investments.
7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.
PLx Pharma's net Intangibles purchase and sale for the
three
months ended in Sep. 2022 was €0.00 Mil.
It means PLx Pharma paid €0.00 Mil for net Intangibles purchase and sale.
8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.
PLx Pharma's cash from discontinued investing activities for the
three
months ended in Sep. 2022 was 0.00 Mil.
It means PLx Pharma paid €0.00 Mil for discontinued investing activities.
9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.
PLx Pharma's cash from other investing activities for the
three
months ended in Sep. 2022 was €0.00 Mil.
It means PLx Pharma paid €0.00 Mil for other investing activities.
PLx Pharma Cash Flow from Investing Related Terms
Thank you for viewing the detailed overview of PLx Pharma's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.
PLx Pharma Winddown Corp Formerly PLx Pharma Inc is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform designed to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the GI tract. It believes this platform has the potential to improve the absorption of many drugs currently on the market or in development and to reduce the risk of stomach erosions and ulcers associated with drugs. VAZALORE is a novel formulation of aspirin clinically shown to provide fast, reliable and predictable platelet inhibition for patients with vascular disease and diabetic patients who may be candidates for aspirin therapy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:1D5A has been successfully added to your 